Related Experiment Video
Updated: May 7, 2026

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Clinical and ethical aspects of financial capacity in dementia: a commentary
1Department of Neurology University of Alabama at Birmingham, Birmingham, Alabama ; Alzheimer's Disease Center University of Alabama at Birmingham, Birmingham, Alabama.
Insights
Financial capacity in dementia is often overlooked, yet crucial for patient well-being. Addressing financial capacity issues in Alzheimer's disease (AD) and Parkinson's disease (PD) is vital for preventing exploitation and ensuring financial security.
Area of Science:
- Geriatric Medicine
- Neuroscience
- Bioethics
Background:
- Financial capacity in dementia patients, including Alzheimer's disease (AD) and Parkinson's disease (PD), is under-addressed in clinical and ethical literature.
- Managing financial capacity presents frequent ethical and clinical challenges for healthcare providers.
- Key issues include assessing independent financial management, need for assessment referral, and identifying financial exploitation or abuse.
Purpose of the Study:
- To provide an overview of financial capacity and related clinical/ethical concerns in dementia.
- To define potential roles for clinicians in managing financial capacity issues.
- To highlight the importance of financial capacity for patient and family well-being.
Main Methods:
- This commentary reviews existing literature and clinical observations on financial capacity in dementia.
- It outlines practical considerations and clinician responsibilities.
- It identifies available educational resources for professionals.
Main Results:
- Accurate identification and management of financial capacity issues significantly impact patient and family financial and psychological health.
- Clinicians face challenges in assessing capacity and protecting patients from exploitation.
- There is a need for greater focus on this neglected area.
Conclusions:
- Financial capacity is a critical, yet often overlooked, aspect of dementia care.
- Clinicians require guidance and resources to effectively address financial capacity issues.
- Elevating attention to financial capacity is essential for patients, families, and legal/healthcare professionals.
Abstract:
In contrast to issues like treatment and research consent capacity, financial capacity has received relatively little clinical and ethical attention in the dementia literature. Yet issues of financial capacity emerge frequently in patients with Alzheimer's disease (AD), Parkinson's disease (PD) and related dementias, and commonly present ethical and clinical challenges for clinicians treating these patients. These issues include whether a patient with possible dementia has sufficient capacity independently to manage their financial affairs, needs referral for financial capacity assessment, and/or is being financially exploited or abused by others. The accurate identification, assessment and successful handling of such financial capacity issues can have a substantial impact on the financial and psychological well-being of patients and their family members. The present commentary presents an overview of financial capacity and associated clinical and ethical issues in dementia, and describes a set of possible clinician roles regarding these issues as they arise in clinical practice. The commentary concludes with a section describing educational resources available to clinicians and bioethicists seeking additional guidance in handling financial capacity issues. The ultimate goal of the paper is to focus clinical and ethical attention on a neglected capacity that is of fundamental importance for patients, families, and health care and legal professionals.
Related Concept Videos
Dementia
The progression of dementia is generally gradual.
Dementia l: Introduction
Alzheimer Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Ethical Dilemmas II
Ethical Issues
Ethical Concerns in Healthcare:
